Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | CAMK2D | Q13557 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | CNR2 | P34972 | 4/20 | 0.46 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CRHBP | P24387 | 1/20 | 0.44 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.44 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29324307 | 0.87 | LMNA (0.53) | CAMK2DLMNACNR2 | |
| SCHEMBL13008033 | 0.86 | LMNA (0.50) | CNR1TDP1CAMK2DLMNACNR2 | |
| SCHEMBL14333263 | 0.86 | CNR1 (0.58) | CNR1CAMK2DLMNACNR2CREBBP | |
| SCHEMBL2013170 | 0.84 | CYP19A1 (0.57) | CNR1CAMK2DLMNACNR2CREBBP | |
| SCHEMBL23915480 | 0.82 | LMNA (0.58) | CNR1TDP1LMNACREBBPALDH1A1 | |
| SCHEMBL9354163 | 0.82 | CAMK2D (0.49) | CNR1CAMK2DLMNACNR2ALDH1A1 | |
| SCHEMBL4656142 | 0.81 | LMNA (0.53) | CNR1TDP1CAMK2DLMNACNR2 | |
| SCHEMBL29324341 | 0.81 | KDM4E (0.50) | TDP1LMNAKDM4EALDH1A1 | |
| SCHEMBL4653711 | 0.80 | P2RX3 (0.41) | CNR1TDP1CAMK2DLMNACNR2 | |
| SCHEMBL18833435 | 0.79 | CNR1 (0.68) | CNR1TDP1LMNACNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024151425-A1 | COMPOUNDS AND METHOD FOR TREATING HIV INFECTION | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-07-18 | — | — | WO | disclosed |